Ignite Creation Date:
2024-05-06 @ 2:33 AM
Last Modification Date:
2024-10-26 @ 11:19 AM
Study NCT ID:
NCT02063789
Status:
COMPLETED
Last Update Posted:
2016-05-25
First Post:
2014-02-13
Brief Title:
An Open Phase 3 Study of IV-Globulin SN Inj10 to Treat Immune Thrombocytopenia
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp
Organization Data
Organization:
GC Biopharma Corp
Class:
INDUSTRY
Study ID:
GC5107A_P3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Green Cross Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None